ReSync Bio logo

ReSync Bio

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

Undisclosed


ReSync Bio develops a platform to streamline data management and operations in preclinical drug discovery by automating coordination and enhancing collaboration between drug discovery teams and their labs.

Total Funding

Undisclosed

Headquarters

San Francisco, USA

Founded

N/A

Website

Focus Areas

scientific software
data management
preclinical drug discovery
AI-driven drug discovery
automation
data organization

Investors

Caffeinated Capital logo
Atria Ventures logo